COMPLETED

HF Patients With LVADs Being Treated With SGLT2i

Talk to us

Conditions

Heart Failure With Reduced Ejection Fractionleft ventricular assist deviceSGLT2i

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The main purpose of this study is to observe outcomes of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in heart failure (HF) patients with left ventricular assist devices (LVAD).

Official Title

Heart Failure Patients With Left Ventricular Assist Devices Being Treated With Sodium-Glucose Co-Transporter 2 Inhibitors

Quick Facts

Study Start:2022-09-08
Study Completion:2025-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05278962

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. LVAD implantation
  2. 2. Have not already been prescribed management with an SGLT2i
  3. 3. Estimated glomerular filtration rate (eGFR) ≥ 30 milliliters(ml)/minute(min)/1.73 meter(m)2
  4. 4. Age ≥ 18 years-old
  5. 5. Able to provide informed consent
  1. 1. Diagnosis of Type 1 diabetes mellitus
  2. 2. eGFR \< 30 ml/min/1.73 m2
  3. 3. Age \< 18 years-old

Contacts and Locations

Principal Investigator

Mark Belkin, MD
PRINCIPAL_INVESTIGATOR
University of Chicago

Study Locations (Sites)

University of Chicago
Chicago, Illinois, 60637
United States

Collaborators and Investigators

Sponsor: University of Chicago

  • Mark Belkin, MD, PRINCIPAL_INVESTIGATOR, University of Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-09-08
Study Completion Date2025-08-31

Study Record Updates

Study Start Date2022-09-08
Study Completion Date2025-08-31

Terms related to this study

Keywords Provided by Researchers

  • left ventricular assist device
  • SGLT2i

Additional Relevant MeSH Terms

  • Heart Failure With Reduced Ejection Fraction